Monte Rosa Therapeutics GLUE
NASDAQ GLUE
$10.50 -0.76 (-6.75%)
At close: Oct 2, 2026 · 4:00 PM EDT

Monte Rosa Therapeutics (GLUE) Return on Capital Employed [ROCE] (2021 - 2026)

Updated

Monte Rosa Therapeutics' Return on Capital Employed [ROCE] was -27.80% in Q2 2026, down 32.27 percentage points from 4.47% a year earlier but up 0.63 percentage points from the prior quarter.

Analysis

Monte Rosa Therapeutics (GLUE) Return on Capital Employed [ROCE] (2021 - 2026) Analysis & Trends

For FY2025, Return on Capital Employed [ROCE] at Monte Rosa Therapeutics came in at -14.28%, up 23.57 percentage points from FY2024.

  • Return on Capital Employed [ROCE] shows a four-year change of +23.83 percentage points (FY2021 to FY2025).
  • In earlier years, Return on Capital Employed [ROCE] was -37.85% in FY2024 (+13.98 pp), -51.83% in FY2023 (-17.65 pp), -34.18% in FY2022 (+3.93 pp) and -38.12% in FY2021.
  • Quarterly Return on Capital Employed [ROCE] has moved between -61.95% (Q4 2023) and 4.47% (Q2 2025) over five years.
  • Compared with a year earlier, Return on Capital Employed [ROCE] was higher in six of the last eight quarters, with an average year-over-year change of +20.54 percentage points.
  • The best year-over-year quarter for Return on Capital Employed [ROCE] over five years was Q1 2025 (a gain of 58.43 percentage points); the worst was Q2 2026 (a drop of 32.27 percentage points).
  • Per Business Quant data, GLUE's Return on Capital Employed [ROCE] in the three quarters before Q2 2026 was -28.43% (Q1 2026), -13.90% (Q4 2025) and 2.44% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 46.74%
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 17.83%
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 17.92%
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 6.28%
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 19.32%
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 9.54%
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 16.66%
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -5.97%
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 11.86%
10 Monte Rosa Therapeutics 894.88 Mn 306.69 Mn - -27.80%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -27.80%
Mar 31, 2026 -28.43%
Dec 31, 2025 -13.90%
Sep 30, 2025 2.44%
Jun 30, 2025 4.47%
Mar 31, 2025 -0.60%
Dec 31, 2024 -36.88%
Sep 30, 2024 -44.79%
Jun 30, 2024 -52.99%
Mar 31, 2024 -59.03%
Dec 31, 2023 -61.95%
Sep 30, 2023 -58.06%
Jun 30, 2023 -48.17%
Mar 31, 2023 -40.09%
Dec 31, 2022 -34.64%
Sep 30, 2022 -30.42%
Jun 30, 2022 -27.82%
Mar 31, 2022 -24.93%
Dec 31, 2021 -20.33%
Sep 30, 2021 -16.89%
API Access

Monte Rosa Therapeutics Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=GLUE&period=max&api_key=YOUR_API_KEY